The company has been the quite achiever, this company now has around $5m cash in its coffers, has started a phase 1/11 human trial and has multiple opportunities for their unique strains-- which are showing significant anti inflammatory characteristics. The results of these trials will hopefully bring everyone's attention to us, and a re rate.
What they haven't been good at , is highlighting and convincing the market of what I believe is their significant potential-- at $40m M/C I believe they are just cheap and continue to add to my holdings. Which other company doing human trials is capitalised at under $100 to $150m-- I can't find one.
Cheers
- Forums
- ASX - By Stock
- NTI
- Ann: Neurotech initiates Phase I/II Open Label Study into Autism
Ann: Neurotech initiates Phase I/II Open Label Study into Autism, page-7
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
|
|||||
Last
7.0¢ |
Change
-0.005(6.67%) |
Mkt cap ! $78.35M |
Open | High | Low | Value | Volume |
7.5¢ | 7.7¢ | 7.0¢ | $51.70K | 726.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 47349 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28500 | 0.069 |
3 | 650000 | 0.068 |
1 | 44790 | 0.067 |
3 | 290000 | 0.066 |
4 | 408000 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 5000 | 1 |
0.071 | 526957 | 1 |
0.072 | 80000 | 1 |
0.073 | 13732 | 1 |
0.074 | 40000 | 1 |
Last trade - 12.37pm 30/08/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
SPONSORED BY The Market Online